Metodika: Do studie bylo zařazeno celkem 237 pacientů s karcinomem prostaty a 229 kontrolních osob s klinicky ověřenou diagnózou benigní hyperplazie.
Methods: The study included a total of 237 patients with prostate cancer and 229 controls with a clinically confirmed diagnosis of benign hyperplasia.